Trademark Search in Canada

ORIMELIA

View On IC.GC.CA

REGISTERED

on 6 Aug 2019

Last Applicant/ Owned by

ABBVIE INC.

1 North Waukegan RoadNorth Chicago, Illinois 60064

Serial Number

1864745 filed on 26^th Oct 2017

Registration Number

TMA1047285 registered on 6^th Aug 2019

Registration expiry Date

6^th Aug 2029

Correspondent Address

BAKER & MCKENZIE LLP

BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO

ONTARIO

M5J2T3

ORIMELIA

Trademark usage description

pharmaceutical preparations and substances for the treatment of endocrine diseases and disorders, namely, hormone disorders, growth disorders, diabete Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for the treatment of endocrine diseases and disorders, namely, hormone disorders, growth disorders, diabetes, hypoglycemia, thyroid cancer, glucagonoma, cardiovascular, cardiopulmonary, genitourinary diseases and disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal diseases and disorders, namely, hormonal imbalance, hyperthyroidism, hypothyroidism, exocrine pancreatic insufficiency (EPI), uterine fibroids and endometriosis

Classification kind code

Mark Details

Serial Number

1864745

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 21^st Mar 2019	Approved
Submitted for opposition 27 on 28^th Jan 2019	Approval Notice Sent
Submitted for opposition 20 on 15^th Nov 2018	Examiner's First Report
Submitted for opposition 80 on 31^st May 2018	Change of Title Registered
Submitted for opposition 22 on 4^th May 2018	Search Recorded
Submitted for opposition 15 on 4^th May 2018	Correspondence Created
Submitted for opposition 15 on 8^th Nov 2017	Correspondence Created
Submitted for opposition 31 on 30^th Oct 2017	Formalized
Submitted for opposition 1 on 27^th Oct 2017	Created
Submitted for opposition 30 on 26^th Oct 2017	Filed